TFA Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-275.8K | $99.7K |
| FY2022 | $414.0K | $-951.3K | $6.6K |
| FY2023 | $431.1K | $-151.8K | $23.1K |
| FY2024 | — | $-375.5K | $37.3K |
| FY2025 | — | $-534.6K | $3.2K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-275.8K | $99.7K |
| FY2022 | $414.0K | $-951.3K | $6.6K |
| FY2023 | $431.1K | $-151.8K | $23.1K |
| FY2024 | — | $-375.5K | $37.3K |
| FY2025 | — | $-534.6K | $3.2K |